Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -0.527M
March 31, 2026 -0.77M
December 31, 2025 -0.522M
September 30, 2025 0.15M
June 30, 2025 -0.429M
March 31, 2025 0.093M
December 31, 2024 0.041M
September 30, 2024 0.144M
June 30, 2024 -0.328M
March 31, 2024 0.599M
December 31, 2023 0.201M
September 30, 2023 1.80M
June 30, 2023 0.139M
March 31, 2023 0.551M
December 31, 2022 0.714M
September 30, 2022 0.407M
June 30, 2022 0.211M
March 31, 2022 0.979M
December 31, 2021 -0.851M
September 30, 2021 -4.06M
June 30, 2021 2.393M
Date Value
March 31, 2021 273.31M
December 31, 2020 2.076M
September 30, 2020 92.68M
June 30, 2020 0.615M
March 31, 2020 0.861M
December 31, 2019 0.724M
September 30, 2019 65.20M
June 30, 2019 49.44M
March 31, 2019 0.831M
December 31, 2018 1.221M
September 30, 2018 0.248M
June 30, 2018 -0.606M
March 31, 2018 -0.941M
December 31, 2017 65.73M
September 30, 2017 0.012M
June 30, 2017 8.453M
March 31, 2017 -0.949M
December 31, 2016 -1.204M
September 30, 2016 -1.281M
June 30, 2016 0.016M
March 31, 2016 48.38M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -0.852M
Codexis, Inc. 0.066M
Frontage Holdings Corp. --
Repligen Corp. -6.20M
Bio-Techne Corp. -33.21M